AnTolRx was founded by Francisco J. Quintana in 2015.

How much funding has AnTolRx raised?

AnTolRx has disclosed $1M raised across 1 round.

Where is AnTolRx headquartered?

AnTolRx is headquartered in Boston, US.

AnTolRx

Boston, US · Founded 2015 · Delaware corporation

AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.

Biotech Healthtech

Founders & leadership

AnTolRx was founded in 2015 by Francisco J. Quintana.

Francisco J. QuintanaScientific Founder, Member of Board of Directors

Mark CarthyFounder and CEO, Member of Board of Directors

Board

Satish JindalBoard director

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2016

▶$1MraisedJul 2016 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Satish JindalDirector
Francisco QuintanaDirector
Mark CarthyExecutive Officer, Director

Offering amount: $4M
Amount sold: $1M
First sale: Jun 2016
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Mission BioCapital Platinum Program Holdings LLC3 shared keywordsMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.

TellBio3 shared keywordsTellBio is a biotechnology company founded by leading cancer researchers and clinicians from Harvard Medical School and Massachusetts General Hospital. The company focuses on oncology research and development, leveraging circulating tumor cell (CTC) technology and biomedical engineering.

Companies competing with AnTolRx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does AnTolRx do?: AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.
Who founded AnTolRx?: AnTolRx was founded by Francisco J. Quintana in 2015.
How much funding has AnTolRx raised?: AnTolRx has disclosed $1M raised across 1 round.
Where is AnTolRx headquartered?: AnTolRx is headquartered in Boston, US.